RecruitingNot ApplicableNCT07462481

Probiotic Improve Constipation

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Probiotics in Relieving Constipation in Adults


Sponsor

Wecare Probiotics Co., Ltd.

Enrollment

105 participants

Start Date

Jun 10, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

To evaluate the efficacy and safety of probiotic as a food supplement in regulating bowel habits in patients with chronic constipation, and to compare it with placebo.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a probiotic supplement can help relieve constipation. Researchers want to find out if taking specific beneficial bacteria improves how often and how easily people have bowel movements. **You may be eligible if...** - You are between 18 and 65 years old - You have constipation (fewer than 3 bowel movements per week or very hard stools) - You are able to follow the study protocol throughout the trial - You do not plan to have children during the study period and agree to use contraception **You may NOT be eligible if...** - You are currently taking other supplements or products that may affect digestion - You changed your diet during the study - You have severe allergies or a weakened immune system - You are pregnant, breastfeeding, or planning to become pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTProbiotic

The intervention period of this study will last for 8 weeks (56 days), during which each participant will attend three study visits scheduled at baseline (Week 0), Week 4, and Week 8.

DIETARY_SUPPLEMENTPlacebo

The intervention period of this study will last for 8 weeks (56 days), during which each participant will attend three study visits scheduled at baseline (Week 0), Week 4, and Week 8.

DIETARY_SUPPLEMENTHigh-activity probiotic probiotic

The intervention period of this study will last for 8 weeks (56 days), during which each participant will attend three study visits scheduled at baseline (Week 0), Week 4, and Week 8.


Locations(1)

Suzhou Ninth People's Hospital

Suzhou, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07462481


Related Trials